Beyond the Infusion Chair: Practical Implications of Subcutaneous Immunotherapies

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 42 Minutes

Overview

The development of subcutaneous immunotherapies is reshaping how immune checkpoint inhibitors are delivered, with important implications beyond the traditional infusion center. This educational session examines currently approved and emerging subcutaneous formulations, highlighting pharmacokinetic considerations, safety profiles, and practical differences compared with intravenous administration. 

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

  1. Identify alternative formulations of immunotherapeutics that are currently available or under clinical development
  2. Discuss the practical challenges associated with outpatient administration of subcutaneous immunotherapies
  3. Examine the patient safety considerations and care delivery factors associated with transitioning immunotherapeutic agents to self- administration or home-based-injection
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
01/20/2026
Course expires: 
01/23/2027
Cost:
$0.00
Rating: 
0

Faculty

Robin Tumlinson, PharmD, BCOP

Clinical Pharmacist 
Genitourinary Oncology
Vanderbilt University Medical Center
Nashville, TN

Dr. Tumlinson is a board-certified oncology pharmacist practicing in the Genitourinary Oncology Clinic at Vanderbilt University Medical Center. She received her undergraduate and Doctor of Pharmacy degrees from Auburn University. She then completed a PGY1 Pharmacy Practice Residency at the University of Tennessee Medical Center followed by a PGY2 Oncology Pharmacy Residency at Duke University Hospital before joining the Vanderbilt team in 2024. 

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Robin Tumlinson, PharmD, BCOP   discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above